A watch that detects a sugar drop while sleeping will undergo clinical trials

The "Nite-Sense" company, which developed a watch that detects hypoglycemia in children with diabetes during sleep, will begin clinical trials in medical centers in Israel

The "Night-Sense" watch, developed by Gadi Kantor, Yoav Ken-Tor and Shai Hefetz of the "Night Sense" company, is designed to detect hypoglycemia (a drop in the amount of blood sugar) in children with diabetes during sleep and to call the appropriate authorities when necessary. Daria Dagan
The watch is attached to the child's wrist at night and monitors physiological parameters during sleep such as breathing, pulse, sweating and more. When the watch detects hypoglycemia, it automatically alerts a caregiver such as a relative, or an emergency center. In addition, the device's advanced technology allows it to transfer the data to a care provider for analysis.
The watch will undergo clinical trials at a leading medical center in Israel within two months.

The experiments will be performed under all the required regulatory rules of both the European Union and the FDA.

The "Night-Sense" watch works according to an algorithm that compares the data that the watch detects in the child in real time, with the data that describes hypoglycemia events. When the values ​​of these parameters correspond to the values ​​typical of the state of hypoglycemia, the watch works to alert the relevant party.

The combination is done precisely. It was very important to choose the set of the right sensors and the measurement techniques suitable for the position of the watch and the necessary parameters, as well as in the choice of algorithms that allow high-precision detection of hypoglycemia events. A patent application has been submitted for this unique technology.

The Night-Sense company was founded by Gadi Ken-Tor, an entrepreneur in the field of technology, along with two other entrepreneurs - Shai Hefetz and Yoav Ken-Tor, who had a similar background. Each of them has a personal connection to the problem of diabetes. Gadi the CEO, for example, is diabetic himself, while the other team members Shai and Yoav are sons of parents dealing with this problem.
Hypoglycemia was a condition in which a person has too little sugar in the bloodstream, this is an event that every diabetic who uses insulin is familiar with. There are 90 million diabetics who use insulin who experience such events and the number is constantly increasing, due to the increased use of insulin and the increase in the number of diabetics. Hypoglycemia events during sleep may harm a diabetic and even endanger his life. The functioning of many systems in the body may be damaged as a result of such events. The brain, whose main source of energy is glucose, may be the main victim. This situation is so dangerous that according to the CDC data, 5% of juvenile diabetes patients will die as a result of a hypoglycemic event.

With this in mind, the "Night-Sense" watch was developed to monitor and warn, in times of danger.
Currently there is no dedicated solution on the market for the problem of hypoglycemia during sleep, parents of children with juvenile diabetes choose to proactively get up during the night to check the child's blood sugar level. The problem with this process, beyond the significant damage to the parent's quality of life, is that the test is spot-on, it could be that the child has just come out of a hypoglycemic event and it could be that the event starts fifteen minutes after the test. In addition, the process exposes the child to unnecessary finger pricks every night.

Most of the dangerous events occur during sleep, during the day the diabetic is awake and aware and able to sense when something is starting to go wrong in addition, he is usually not alone and people around him are able to notice that something is not right. In case the patient recognizes that he is in a hypoglycemic episode, he should usually eat something sweet. The problem begins during sleep, the patient is asleep and does not always wake up in time as a result of an event and sometimes does not even wake up at all.
There are continuous solutions but they are very expensive and invasive, they require the insertion of a needle into the body several times a week. The cost of the devices reaches thousands of shekels per month and is usually not covered by insurance companies and health funds. These solutions are also not intended for detecting hypoglycemia during sleep.

The watch for detecting hypoglycemia during sleep, works with non-invasive means and is designed to improve the patient's quality of life and allow him and his family members to sleep safely and know that he has protection from hypoglycemia events during sleep without creating discomfort. The device will even help the medical insurance companies (and health insurance funds) because the costs of treating each serious event are very high and can reach thousands of dollars for each serious event.

The company is in the development stages of a device the size of a wristwatch, which includes both a processor and sensors capable of both measuring the physiological parameters and performing advanced processing. The device is actually able to perform all the operations that will be required of the final product and is designed to meet all the required medical standards. The watch is designed to complement today's treatment method, help patients use insulin optimally and provide more information to the doctor to optimize the quality of treatment. The development of Night-Sense received the warm blessing of several experts in the field, the goal is to improve the quality of life of the diabetic community in the world, a community of which the Night-Sense entrepreneurs are a part.

The article is based on a company announcement.